PortfoliosLab logo

Alzamend Neuro, Inc. (ALZN)

Equity · Currency in USD · Last updated Feb 2, 2023

Company Info

ISINUS02262M3088
CUSIP02262M308
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$0.68
Year Range$0.53 - $1.48
EMA (50)$0.77
EMA (200)$1.00
Average Volume$360.65K
Market Capitalization$65.57M

ALZNShare Price Chart


Loading data...

ALZNPerformance

The chart shows the growth of $10,000 invested in Alzamend Neuro, Inc. in Sep 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $504 for a total return of roughly -94.96%. All prices are adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%40.00%60.00%OctoberNovemberDecember2023February
-27.27%
3.84%
ALZN (Alzamend Neuro, Inc.)
Benchmark (^GSPC)

ALZNCompare to other instruments

Search for stocks, ETFs, and funds to compare with ALZN

Alzamend Neuro, Inc.

Popular comparisons: ALZN vs. SAVA

ALZNReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M20.35%7.29%
YTD20.35%7.29%
6M-24.78%0.68%
1Y-55.56%-8.78%
5Y-84.00%-1.85%
10Y-84.00%-1.85%

ALZNMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202317.52%
20221.80%31.49%-1.68%-1.71%-50.87%

ALZNSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Alzamend Neuro, Inc. Sharpe ratio is -0.72. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.80-0.60-0.40-0.20OctoberNovemberDecember2023February
-0.72
-0.36
ALZN (Alzamend Neuro, Inc.)
Benchmark (^GSPC)

ALZNDividend History


Alzamend Neuro, Inc. doesn't pay dividends

ALZNDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%OctoberNovemberDecember2023February
-94.96%
-14.12%
ALZN (Alzamend Neuro, Inc.)
Benchmark (^GSPC)

ALZNWorst Drawdowns

The table below shows the maximum drawdowns of the Alzamend Neuro, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Alzamend Neuro, Inc. is 96.07%, recorded on Dec 28, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.07%Jun 16, 2021388Dec 28, 2022

ALZNVolatility Chart

Current Alzamend Neuro, Inc. volatility is 59.79%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%OctoberNovemberDecember2023February
59.79%
15.59%
ALZN (Alzamend Neuro, Inc.)
Benchmark (^GSPC)